Business Context and Reporting Period
Company: McKesson Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: December 30, 2010
Event: Completion of the acquisition of US Oncology Holdings, Inc.
Key Financial Metrics
This filing is a regulatory disclosure of a corporate event and does not contain specific financial statements, revenue figures, profit margins, cash flow data, debt levels, or liquidity metrics for the reporting period.
Material Changes
The primary material change disclosed is the successful completion of McKesson Corporation's acquisition of US Oncology Holdings, Inc. on December 30, 2010.
Guidance, Outlook, and Risks
The filing references a press release (Exhibit 99.1) regarding the acquisition but does not include specific management commentary, future guidance, risk factors, or contingencies within the text of the Form 8-K itself. The document explicitly states that the information is furnished but not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Review the attached press release (Exhibit 99.1) for specific transaction terms and financial impact.
- Verify the integration timeline and expected synergies of US Oncology Holdings, Inc.
- Check subsequent quarterly filings (10-Q) or annual reports (10-K) for the consolidated financial impact of this acquisition.
- Confirm any regulatory approvals or conditions associated with the acquisition closure.